What We're Reading: Page
Industry reads hand-picked by our editors
Jan 16, 2026
Jan 15, 2026
-
Reuters
US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
-
The New York Times
China’s ‘Dr. Frankenstein’ Thinks Time Is on His Side
-
The Atlantic
The Best Flu Drug Americans Aren’t Taking
-
The Financial Times
Vaccines are no longer immune to pharma’s market swings
Jan 14, 2026
Jan 13, 2026
Jan 12, 2026
Jan 09, 2026
-
The Financial Times
Merck in talks to buy cancer drugmaker Revolution Medicines for up to $32bn
-
The Boston Globe
‘A little bit more certainty’: After shaky years, Mass. life science companies find glimmers of hope
-
CNBC
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Previous
